[ET Net News Agency, 7 August 2026] GENSCRIPT BIO (01548) rose 9.7% to HK$21.7.
It hits an intra-day high of HK$21.76, hitting a 52-week high, and an intra-day low of HK$19.27. The total shares traded was 49.71 million, with a value of HK$1b. The active buy/sell ratio is 62:38, with net buying turnover of HK$187.61m. J.P. MORGAN BRO (HK) accounts for greatest net responsive buying turnover of HK$42.32m, with volume weighted average price of HK$20.397. CHINA INNOVATION MARKET SER accounts for greatest net responsive selling turnover of HK$34.09m, with volume weighted average price of HK$20.565. The stock has risen a combined 33.1% over the past 4 consecutive trading days.
Basic Information| Nominal | 21.700 | % Chg | +9.71% |
| High | 21.760 | Low | 19.270 |
| Shares Tr | 49.71m | Turnover | 1b |
| 10-D SMA | 18.105 | %H.V | 78.765 |
| 20-D SMA | 16.435 | VWAP | 20.139 |
| 50-D SMA | 14.066 | RSI14 | 76.627 |
Status: Hitting a 52-week high, active buy/sell ratio is 62:38, with net buying turnover of HK$187.61m, rising a combined 33.1% over the past 4 consecutive trading days
Performance of stocks in the same sector or of relevance| Stock (Code) | Price (HK$) | Change (%) |
|---|
| GENSCRIPT BIO (01548) | 21.700 | +9.71 |
| INNOVENT BIO (01801) | 92.800 | +2.03 |
| XTALPI (02228) | 7.455 | +3.04 |
| WUXI XDC (02268) | 61.550 | +11.10 |
| WUXI BIO (02269) | 44.760 | +8.17 |
| WUXI APPTEC (02359) | 190.700 | +6.12 |
| TRANSTHERA-B (02617) | 12.230 | +6.07 |
| BEONE MEDICINES (06160) | 204.800 | +2.66 |
| AKESO (09926) | 99.250 | +3.33 |
| REMEGEN (09995) | 84.600 | +6.42 |
(ed)
